Ian Reddin

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

R. Pengelly, K. Thway, J. Selfe, 2023, Clinical Epigenetics.

Combination EZH2 inhibition and retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

Ian G. Reddin, W. Tapper, A. Kelsey, 2023, bioRxiv.